Your browser doesn't support javascript.
loading
Differences in Stroke Recurrence Risk Between Atrial Fibrillation Detected on ECG and 14-Day Cardiac Monitoring.
Alvarado-Bolaños, Alonso; Ayan, Diana; Khaw, Alexander V; Mai, Lauren M; Mandzia, Jennifer L; Bogiatzi, Chrysi; Mrkobrada, Marko; Bres-Bullrich, Maria; Fleming, Lorraine A; Lippert, Corbin; Fridman, Sebastian; Sposato, Luciano A.
Afiliação
  • Alvarado-Bolaños A; Department of Clinical Neurological Sciences (A.A.-B., A.V.K., L.M.M., J.L.M., C.B., M.B.-B., C.L., S.F., L.A.S.), Western University, London, Canada.
  • Ayan D; Schulich School of Medicine and Dentistry, Heart & Brain Laboratory (D.A., L.A.F., L.A.S.), Western University, London, Canada.
  • Khaw AV; Department of Clinical Neurological Sciences (A.A.-B., A.V.K., L.M.M., J.L.M., C.B., M.B.-B., C.L., S.F., L.A.S.), Western University, London, Canada.
  • Mai LM; Department of Clinical Neurological Sciences (A.A.-B., A.V.K., L.M.M., J.L.M., C.B., M.B.-B., C.L., S.F., L.A.S.), Western University, London, Canada.
  • Mandzia JL; Department of Clinical Neurological Sciences (A.A.-B., A.V.K., L.M.M., J.L.M., C.B., M.B.-B., C.L., S.F., L.A.S.), Western University, London, Canada.
  • Bogiatzi C; Department of Clinical Neurological Sciences (A.A.-B., A.V.K., L.M.M., J.L.M., C.B., M.B.-B., C.L., S.F., L.A.S.), Western University, London, Canada.
  • Mrkobrada M; Department of Medicine (M.M.), Western University, London, Canada.
  • Bres-Bullrich M; Department of Clinical Neurological Sciences (A.A.-B., A.V.K., L.M.M., J.L.M., C.B., M.B.-B., C.L., S.F., L.A.S.), Western University, London, Canada.
  • Fleming LA; Schulich School of Medicine and Dentistry, Heart & Brain Laboratory (D.A., L.A.F., L.A.S.), Western University, London, Canada.
  • Lippert C; Department of Clinical Neurological Sciences (A.A.-B., A.V.K., L.M.M., J.L.M., C.B., M.B.-B., C.L., S.F., L.A.S.), Western University, London, Canada.
  • Fridman S; Department of Clinical Neurological Sciences (A.A.-B., A.V.K., L.M.M., J.L.M., C.B., M.B.-B., C.L., S.F., L.A.S.), Western University, London, Canada.
  • Sposato LA; Department of Clinical Neurological Sciences (A.A.-B., A.V.K., L.M.M., J.L.M., C.B., M.B.-B., C.L., S.F., L.A.S.), Western University, London, Canada.
Stroke ; 54(8): 2022-2030, 2023 08.
Article em En | MEDLINE | ID: mdl-37377007
ABSTRACT

BACKGROUND:

Ischemic stroke and transient ischemic attack (TIA) standard-of-care etiological investigations include an ECG and prolonged cardiac monitoring (PCM). Atrial fibrillation (AF) detected after stroke has been generally considered a single entity, regardless of how it is diagnosed. We hypothesized that ECG-detected AF is associated with a higher risk of stroke recurrence than AF detected on 14-day Holter (PCM-detected AF).

METHODS:

We conducted a retrospective, registry-based, cohort study of consecutive patients with ischemic stroke and TIA included in the London Ontario Stroke Registry between 2018 and 2020, with ECG-detected and PCM-detected AF lasting ≥30 seconds. We quantified PCM-detected AF burden. The primary outcome was recurrent ischemic stroke, ascertained by systematically reviewing all medical records until November 2022. We applied marginal cause-specific Cox proportional hazards models adjusted for qualifying event type (ischemic stroke versus TIA), CHA2DS2-VASc score, anticoagulation, left ventricular ejection fraction, left atrial size, and high-sensitivity troponin T to estimate adjusted hazard ratios for recurrent ischemic stroke.

RESULTS:

We included 366 patients with ischemic stroke and TIA with AF, 218 ECG-detected, and 148 PCM-detected. Median PCM duration was 12 (interquartile range, 8.8-14.0) days. Median PCM-detected AF duration was 5.2 (interquartile range, 0.3-33.0) hours, with a burden (total AF duration/total net monitoring duration) of 2.23% (interquartile range, 0.13%-12.25%). Anticoagulation rate at the end of follow-up or at the first event was 83.1%. After a median follow-up of 17 (interquartile range, 5-34) months, recurrent ischemic strokes occurred in 16 patients with ECG-detected AF (13 on anticoagulants) and 2 with PCM-detected AF (both on anticoagulants). Recurrent ischemic stroke rates for ECG-detected and PCM-detected AF groups were 4.05 and 0.72 per 100 patient-years (adjusted hazard ratio, 5.06 [95% CI, 1.13-22.7]; P=0.034).

CONCLUSIONS:

ECG-detected AF was associated with 5-fold higher adjusted recurrent ischemic stroke risk than PCM-detected AF in a cohort of ischemic stroke and TIA with >80% anticoagulation rate.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Ataque Isquêmico Transitório / Acidente Vascular Cerebral / AVC Isquêmico Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Stroke Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Ataque Isquêmico Transitório / Acidente Vascular Cerebral / AVC Isquêmico Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Stroke Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá